Perspective from Ecuador, the Second Country with More Confirmed Cases of Coronavirus Disease 2019 in South America: A Review
Open Access
- 28 March 2020
- journal article
- review article
- Published by Springer Science and Business Media LLC in Cureus
- Vol. 12 (3), e7452
- https://doi.org/10.7759/cureus.7452
Abstract
To face the pandemic outbreak of a novel coronavirus many countries developed a series of containment methods; however, developing countries in South America had reacted apathetically to this worldwide concern. Ecuador's response to the novel virus Coronavirus Disease 2019 (COVID-19) started on February 26, 2020, one month after the outbreak began in China. As of today, the countries with more confirmed cases in South America are Brazil and Ecuador. Although Brazil has two times the number of cases than Ecuador (Brazil: 700 cases per 100000 people vs. Ecuador: 400 cases per 100000), the huge population difference between the two countries raises concerns about the public health policies implemented by the Ecuadorian government. Even though there is no cure for COVID-19, chloroquine and hydroxychloroquine are promising alternatives. The COVID-19 pandemic outbreak has shown that there is room for improvement in the healthcare systems worldwide and the disastrous results on the fragile often unprepared are those systems in developing countries.Keywords
This publication has 10 references indexed in Scilit:
- COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progressionJournal of Antimicrobial Chemotherapy, 2020
- Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020Mmwr. Morbidity and Mortality Weekly Report, 2020
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected PneumoniaNew England Journal of Medicine, 2020
- COVID‐19: Vulnerability and the power of privilege in a pandemicHealth Promotion Journal of Australia, 2020
- New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?International Journal of Antimicrobial Agents, 2020
- Chloroquine and hydroxychloroquine as available weapons to fight COVID-19International Journal of Antimicrobial Agents, 2020
- World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)International Journal of Surgery, 2020
- Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathologySeminars in Immunopathology, 2017
- Molecular Basis of Coronavirus Virulence and Vaccine DevelopmentPublished by Elsevier BV ,2016
- Molecular pathology of emerging coronavirus infectionsThe Journal of Pathology, 2014